Novo Nordisk NOVO.B-0.70%decrease ... shortly after Maziar Mike Doustdar took the reins and at a time the company behind ...

Sales of the drug have declined, eclipsed by soaring demand for Ozempic, which shares the same active ingredient ... All ...

COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug ... Sales of the drug have declined, ...

Multiple lawsuits have been filed against the makers of the popular weight-loss drug. Litigants cite blindness and other side-effects.

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.

In April 2025 , Northstrive Biosciences announced it received preliminary feedback from the FDA on its planned Type B pre-IND ...

Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled off its ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...